日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Elebsiran and PEG-IFNα for chronic hepatitis B infection: a partially randomized, open-label, phase 2 trial

Elebsiran 和 PEG-IFNα 治疗慢性乙型肝炎感染:一项部分随机、开放标签的 II 期试验

Wong, Grace Lai-Hung; Yuen, Man-Fung; Lin, Bingliang; Douglas, Mark W; Hu, Peng; Xie, Qing; Lv, Fangfang; Tak, Won Young; Leerapun, Apinya; Kim, Dong Joon; Tangkijvanich, Pisit; Lim, Young-Suk; Dai, Chia-Yen; O'Beirne, James; Weltman, Martin; Khemnark, Suparat; Piratvisuth, Teerha; Manasirisuk, Witsarut; Chen, Xinyue; Liu, Chun-Jen; Heo, Jeong; Lee, Jooho; Niu, Junqi; Kumar, Rahul; Kumar, Rajneesh; Zhu, Chong; Cao, Ke; Tian, Alex; Chen, Xiaofei; Zhu, Qing; Margolis, David; Jia, Jidong; Hong, Zhi

Impact of cardiometabolic risk factors on hepatocellular carcinoma incidence in patients with chronic hepatitis B: A retrospective cohort study

心血管代谢危险因素对慢性乙型肝炎患者肝细胞癌发病率的影响:一项回顾性队列研究

Toh, Chanavee; Sanit, Kedsiree; Sripongpun, Pimsiri; Chamroonkul, Naichaya; Liangpunsakul, Suthat; Piratvisuth, Teerha; Kaewdech, Apichat

Update on the treatment navigation for functional cure of chronic hepatitis B: Expert consensus 2.0

慢性乙型肝炎功能性治愈治疗导航最新进展:专家共识 2.0

Wu, Di; Kao, Jia-Horng; Piratvisuth, Teerha; Wang, Xiaojing; Kennedy, Patrick T F; Otsuka, Motoyuki; Ahn, Sang Hoon; Tanaka, Yasuhito; Wang, Guiqiang; Yuan, Zhenghong; Li, Wenhui; Lim, Young-Suk; Niu, Junqi; Lu, Fengmin; Zhang, Wenhong; Gao, Zhiliang; Kaewdech, Apichat; Han, Meifang; Yan, Weiming; Ren, Hong; Hu, Peng; Shu, Sainan; Kwo, Paul Yien; Wang, Fu-Sheng; Yuen, Man-Fung; Ning, Qin

Comparative evaluation of multimarker algorithms for early-stage HCC detection in multicenter prospective studies

多中心前瞻性研究中早期肝细胞癌检测多标志物算法的比较评价

Hou, Jinlin; Berg, Thomas; Vogel, Arndt; Piratvisuth, Teerha; Trojan, Jörg; De Toni, Enrico N; Kudo, Masatoshi; Malinowsky, Katarina; Findeisen, Peter; Hegel, Johannes Kolja; Schöning, Wenzel; Madin, Kairat; Kroeniger, Konstantin; Lik-Yuen Chan, Henry; Sharma, Ashish

Roadmap for HCC Surveillance and Management in the Asia Pacific

亚太地区肝细胞癌监测和管理路线图

Kudo, Masatoshi; Oanh, Bui Thi; Chen, Chien-Jen; Ngat, Do Thi; George, Jacob; Kim, Do Young; Pimsawadi, Luckxawan; Tangkijvanich, Pisit; Pwu, Raoh-Fang; Mohamed, Rosmawati; Bunnag, Sakarn; Lu, Sheng-Nan; Kudtiyakarn, Sirintip; Kanto, Tatsuya; Piratvisuth, Teerha; Wu, Chao-Chun; Sarno, Roberta

Comparative performance of the GAAD and ASAP scores in predicting early-stage hepatocellular carcinoma

GAAD评分和ASAP评分在预测早期肝细胞癌方面的比较性能

Maneenil, Chongkonrat; Sripongpun, Pimsiri; Chamroonkul, Naichaya; Tantisaranon, Piraya; Jarumanokul, Roongrueng; Samaeng, Maseetoh; Yamsuwan, Yupawadee; Fonghoi, Lalita; Numit, Amornkan; Piratvisuth, Teerha; Kaewdech, Apichat

Coexisting steatotic liver disease is not associated with long-term liver-related events in patients with chronic hepatitis B

合并脂肪肝疾病与慢性乙型肝炎患者的长期肝脏相关事件无关。

Uman, Navavee; Kaewdech, Apichat; Sripongpun, Pimsiri; Chamroonkul, Naichaya; Piratvisuth, Teerha

A nationwide population-based cross-sectional time series study of hospitalized chronic liver disease burden in Thailand from 2017 to 2022

一项基于全国人口的横断面时间序列研究,探讨了2017年至2022年泰国住院慢性肝病负担。

Saehan, Rungfah; Kaewdech, Apichat; Sripongpun, Pimsiri; Chamroonkul, Naichaya; Piratvisuth, Teerha; Liangpunsakul, Suthat; Kumwichar, Ponlagrit

Effect of switching from prior Nucleos(t)ide Analogue(s) to Tenofovir alafenamide on lipid profile and cardiovascular risk in patients with Chronic Hepatitis B

慢性乙型肝炎患者从既往核苷(酸)类似物换用替诺福韦艾拉酚胺对血脂谱和心血管风险的影响

Praguylertluck, Witchayaporn; Kaewdech, Apichat; Chamroonkul, Naichaya; Piratvisuth, Teerha; Sripongpun, Pimsiri

Changes in the epidemiological trends of primary liver cancer in the Asia-Pacific region

亚太地区原发性肝癌流行病学趋势的变化

Danpanichkul, Pojsakorn; Suparan, Kanokphong; Sukphutanan, Banthoon; Kaeosri, Chuthathip; Tothanarungroj, Primrose; Sirimangklanurak, Supapitch; Kalligeros, Markos; Polpichai, Natchaya; Pang, Yanfang; Wijarnpreecha, Karn; Sripongpun, Pimsiri; Chamroonkul, Naichaya; Nguyen, Mindie H; Liangpunsakul, Suthat; Piratvisuth, Teerha; Kaewdech, Apichat